Mukka Proteins Limited Stock Price Today (NSE: MUKKA)
Fundamental Score
Mukka Proteins Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Mukka Proteins Limited share price today is ₹28.57, up +1.03% on NSE/BSE as of 18 September 2026. Mukka Proteins Limited (MUKKA) is a Small-cap company in the Animal Feed sector with a market capitalisation of ₹857.10 (Cr). The 52-week high for MUKKA share price is ₹33.29 and the 52-week low is ₹18.27. At a P/E ratio of 12.37x, MUKKA is currently trading below its industry average P/E of 21.96x. The company has a Return on Equity (ROE) of 11.08% and a debt-to-equity ratio of 1.54.
Mukka Proteins Limited Share Price Chart — NSE/BSE Historical Performance
Mukka Proteins Limited share price chart: 27.32% return over the past month. 52-week high ₹33.29, 52-week low ₹18.27.
Mukka Proteins Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹31.10 | ₹31.31 | ₹29.26 | ₹29.53 | 13.56L (Cr) | |
| ₹33.00 | ₹33.29 | ₹30.95 | ₹31.39 | 22.84L (Cr) | |
| ₹30.57 | ₹33.00 | ₹28.56 | ₹32.17 | 19.10L (Cr) | |
| ₹30.35 | ₹31.00 | ₹29.87 | ₹30.57 | 8.74L (Cr) | |
| ₹30.49 | ₹31.20 | ₹28.16 | ₹29.86 | 17.17L (Cr) | |
| ₹32.53 | ₹32.78 | ₹30.34 | ₹30.72 | 18.63L (Cr) | |
| ₹31.50 | ₹33.22 | ₹31.11 | ₹32.15 | 52.10L (Cr) | |
| ₹29.99 | ₹32.44 | ₹28.96 | ₹31.34 | 69.10L (Cr) | |
| ₹26.99 | ₹28.92 | ₹26.90 | ₹28.72 | 33.70L (Cr) | |
| ₹27.19 | ₹27.50 | ₹26.60 | ₹26.85 | 9.66L (Cr) |
Mukka Proteins Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹24.98 | ₹33.29 | ₹24.61 | ₹29.53 | +18.21% | |
| ₹22.70 | ₹28.23 | ₹22.70 | ₹24.81 | +9.30% | |
| ₹23.75 | ₹25.00 | ₹21.50 | ₹22.54 | -5.09% | |
| ₹22.68 | ₹25.87 | ₹21.00 | ₹23.82 | +5.03% | |
| ₹24.10 | ₹25.49 | ₹22.20 | ₹22.79 | -5.44% | |
| ₹19.49 | ₹24.88 | ₹19.01 | ₹24.03 | +23.29% | |
| ₹21.00 | ₹23.53 | ₹18.27 | ₹18.49 | -11.95% | |
| ₹23.05 | ₹26.50 | ₹22.33 | ₹22.76 | -1.26% | |
| ₹24.14 | ₹24.18 | ₹20.16 | ₹23.30 | -3.48% | |
| ₹25.40 | ₹30.26 | ₹23.65 | ₹24.02 | -5.43% | |
| ₹25.05 | ₹27.50 | ₹23.80 | ₹25.29 | +0.96% | |
| ₹26.14 | ₹27.65 | ₹24.10 | ₹25.18 | -3.67% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Mukka Proteins Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Mukka Proteins Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MUKKA across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Excellent ROCE Performance (24.42%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 12.37 vs Industry: 21.96)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (1145.02%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Strong Revenue Growth (186.73%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (19.14% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (52.61% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (73.33%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Elevated Debt Levels (D/E: 1.54)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (2.36x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Negative Free Cash Flow (₹-602.80 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 1.70%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Mukka Proteins Limited vs Animal Feed Peers
Peer Comparison - Animal Feed
Compare Mukka Proteins Limited with 7 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Mukka Proteins LimitedMukka Proteins ...Selected✓ MUKKA • 544135 | 46.1/100 | ₹28.57₹29 | ₹857.10₹857.10 | 12.37Average 12.4 Average | 11.08%Average 11.08% Average | 24.42%Excellent 24.42% Excellent | 1.54Average 1.5 Average | 52.61%Excellent 52.61% Excellent | 19.14%Excellent 19.14% Excellent | 0.00% |
Godrej Agrovet LimitedGodrej Agrovet ... GODREJAGRO • 540743 | 52.7/100 | ₹673.05₹673 | ₹12946.79₹12946.79 | 28.99Average 29.0 Average | 20.18%Excellent 20.18% Excellent | 21.67%Excellent 21.67% Excellent | 0.72Good 0.7 Good | 7.25%Good 7.25% Good | 10.30%Good 10.30% Good | 1.91% |
Avanti Feeds LimitedAvanti Feeds Li... AVANTIFEED • 512573 | 53.6/100 | ₹815.30₹815 | ₹11108.14₹11108.14 | 20.92Average 20.9 Average | 19.91%Good 19.91% Good | 25.30%Excellent 25.30% Excellent | 0.00Excellent 0.0 Excellent | 10.98%Good 10.98% Good | 8.15%Good 8.15% Good | 0.91% |
KSE LimitedKSE Limited... KSE • 519421 | 32.6/100 | ₹178.69₹179 | ₹592.96₹592.96 | 7.06Average 7.1 Average | 26.01%Excellent 26.01% Excellent | 33.56%Excellent 33.56% Excellent | 0.07Excellent 0.1 Excellent | -4.88%Poor -4.88% Poor | 1.72%Average 1.72% Average | 4.32% |
Shivansh Finserve LtdShivansh Finser... SHIVA • 544165 | 38.6/100 | ₹119.35₹119 | ₹74.47₹74.47 | 15.81Average 15.8 Average | 70.35%Excellent 70.35% Excellent | 8.01%Poor 8.01% Poor | 0.43Excellent 0.4 Excellent | — — | — — | 0.00% |
44.4/100 | ₹3.50₹4 | ₹60.29₹60.29 | 14.58Average 14.6 Average | 4.82%Poor 4.82% Poor | 7.06%Poor 7.06% Poor | 0.19Excellent 0.2 Excellent | 63.23%Excellent 63.23% Excellent | 29.01%Excellent 29.01% Excellent | 0.00% | |
Mayank Cattle Food LtdMayank Cattle F... MCFL • 544106 | 42/100 | ₹107.35₹107 | ₹57.97₹57.97 | 19.29Average 19.3 Average | 17.16%Good 17.16% Good | 28.45%Excellent 28.45% Excellent | 1.05Average 1.0 Average | 52.92%Excellent 52.92% Excellent | 16.74%Excellent 16.74% Excellent | 0.00% |
Narmada Agrobase LimitedNarmada Agrobas... NARMADA • 543643 | 42.2/100 | ₹14.05₹14 | ₹53.30₹53.30 | 14.79Average 14.8 Average | 6.70%Poor 6.70% Poor | 10.27%Average 10.27% Average | 0.17Excellent 0.2 Excellent | 40.30%Excellent 40.30% Excellent | 5.93%Good 5.93% Good | 0.00% |
Top Animal Feed Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Godrej Agrovet Limited share price12946.79 Cr
- Avanti Feeds Limited share price11108.14 Cr
- KSE Limited share price592.96 Cr
- Shivansh Finserve Ltd share price74.47 Cr
- Ajooni Biotech Limited share price60.29 Cr
Mukka Proteins Limited PE Ratio History
Historical price-to-earnings ratio for MUKKA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹3.10 | ₹41.24 | 13.3x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Mukka Proteins Limited Quarterly Performance
Latest quarterly metrics for MUKKA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
186.73%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
1145.02%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
19.14%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
52.61%
Compounded annual net profit growth over 5 years
Mukka Proteins Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for MUKKA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Mukka Proteins Limited Financial Statements
Annual income statement, balance sheet and cash flow for Mukka Proteins Limited (MUKKA) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Mukka Proteins Limited
About MUKKA (Mukka Proteins Limited)
Mukka Proteins Ltd is a pioneering force in the animal feed industry, specializing in the sustainable production of high-quality protein ingredients derived from fish and insects. ...With a commitment to innovation and environmental responsibility, Mukka Proteins transforms marine and insect resources into valuable components for various sectors. The company’s state-of-the-art facilities employ advanced processing techniques to ensure optimal nutrient retention and product purity. Mukka Proteins is dedicated to meeting the evolving needs of the animal feed market while minimizing its ecological footprint. Their products offer a superior alternative to conventional protein sources, promoting healthier animal growth and improved overall nutrition. Mukka Proteins Ltd offers a comprehensive portfolio of products tailored to diverse applications. Their flagship offerings include fish meal, fish oil, and fish soluble paste, all meticulously crafted to provide essential amino acids, omega-3 fatty acids, and other vital nutrients for aqua feed, poultry feed, and pet food formulations. Furthermore, Mukka Proteins extends its expertise to insect-based ingredients with ento meal, ento oil, and compost, harnessing the potential of insects as a sustainable protein source. These innovative products cater to the growing demand for eco-friendly and nutritionally superior feed ingredients. Beyond animal nutrition, the company supplies raw materials for industrial uses such as soap manufacturing, leather tanning, and paint production. With a global outlook, Mukka Proteins Ltd has established a robust export network, serving customers across Asia and beyond. Their commitment to quality and reliability has earned them a reputation as a trusted supplier in international markets. By providing consistent product performance and exceptional customer service, Mukka Proteins fosters long-term partnerships with businesses worldwide. As the animal feed industry continues to prioritize sustainability and nutritional excellence, Mukka Proteins is poised to play a key role in shaping the future of animal nutrition with its innovative product offerings and commitment to responsible resource management.
Company Details
Key Leadership
MUKKA Share Price: Frequently Asked Questions
What is the current share price of Mukka Proteins Limited?
Mukka Proteins Limited (MUKKA) trades at ₹28.57 on NSE and BSE. Market cap ₹857.10 (Cr). Educational data only.
What is the P/E ratio of Mukka Proteins Limited?
Mukka Proteins Limited has a P/E of 12.37x vs industry average 21.96x.
What is the Bull Run score for Mukka Proteins Limited?
Mukka Proteins Limited has a Bull Run score of 46.1/100 based on 25+ financial parameters.
Does Mukka Proteins Limited pay dividends?
Mukka Proteins Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Mukka Proteins Limited?
Mukka Proteins Limited has ROE of 11.08%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Mukka Proteins Limited?
Mukka Proteins Limited has debt-to-equity of 1.54.
Is Mukka Proteins Limited a good investment?
Bull Run gives Mukka Proteins Limited a score of 46.1/100. This is not investment advice — consult a SEBI-registered advisor.